Marie C Hasselluhn

5PUBLICATIONS
49CO-AUTHORS
Molecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 12, 2024
Author Correction: Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.

Urszula N Wasko, Jingjing Jiang, Tanner C Dalton

|Sep 16, 2024
Pancreatic Cancer-Associated Fibroblasts: Where Do We Go from Here?

Eileen S Carpenter, Debora Barbosa Vendramini-Costa, Marie C Hasselluhn

|May 15, 2024
"Tumor-selective treatment of metastatic pancreatic cancer with an engineered, probiotic living drug".

Amanda R Decker-Farrell, Stephen A Sastra, Tetsuhiro Harimoto

|Apr 08, 2024
Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer.

Urszula N Wasko, Jingjing Jiang, Tanner C Dalton

|Nov 15, 2023
Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression.

Marie C Hasselluhn, Amanda R Decker-Farrell, Lukas Vlahos

Pageof 1